JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares S&P 500 Value ETF
IVE
|
+$2.05B |
| 2 |
iShares S&P 500 Growth ETF
IVW
|
+$1.92B |
| 3 |
iShares Core US Aggregate Bond ETF
AGG
|
+$1.13B |
| 4 |
iShares Russell 1000 Value ETF
IWD
|
+$1.1B |
| 5 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$1.06B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Japan ETF
BBJP
|
+$1.24B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$1.12B |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$989M |
| 4 |
Microsoft
MSFT
|
+$973M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$931M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.54% |
| 2 | Technology | 14.97% |
| 3 | Healthcare | 10.91% |
| 4 | Financials | 10.87% |
| 5 | Consumer Discretionary | 8.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2451
Coherent
COHR
$65.3B
| $3.4M | ﹤0.01% |
119,171
-12,457
| -9% | -$405K |
2013 Q2
27 quarters
|
|
2452
Toyota
TM
$218B
| $3.4M | ﹤0.01% |
28,301
+1,516
| +6% | +$202K |
2013 Q2
27 quarters
|
|
2453
Cactus
WHD
$4.52B
| $3.39M | ﹤0.01% |
292,147
+233,984
| +402% | +$5.88M |
2018 Q1
8 quarters
|
|
|
HIO
2454
Western Asset High Income Opportunity Fund
HIO
$308M
| $3.38M | ﹤0.01% |
803,199
+707,954
| +743% | +$3.4M |
2016 Q4
13 quarters
|
|
2455
Tanger
SKT
$3.97B
| $3.37M | ﹤0.01% |
674,542
+307,498
| +84% | +$3.76M |
2013 Q2
27 quarters
|
|
2456
First Trust NASDAQ Technology Dividend Index Fund
TDIV
$4.5B
| $3.36M | ﹤0.01% |
95,042
+4,382
| +5% | +$181K |
2013 Q2
27 quarters
|
|
2457
Kaiser Aluminum
KALU
$2.55B
| $3.36M | ﹤0.01% |
48,506
+19,058
| +65% | +$1.79M |
2013 Q2
27 quarters
|
|
|
EVRI
2458
DELISTED
Everi Holdings
EVRI
| $3.36M | ﹤0.01% |
1,017,266
+338,035
| +50% | +$3.45M |
2017 Q1
12 quarters
|
|
2459
World Acceptance Corp
WRLD
$822M
| $3.36M | ﹤0.01% |
61,453
+54
| +0.1% | +$4.18K |
2016 Q3
14 quarters
|
|
|
BPFH
2460
DELISTED
Boston Private Financial Holdings, Inc.
BPFH
| $3.35M | ﹤0.01% |
468,583
+91,762
| +24% | +$945K |
2013 Q2
27 quarters
|
|
2461
Exponent
EXPO
$3.27B
| $3.35M | ﹤0.01% |
46,529
+14,674
| +46% | +$1.07M |
2013 Q2
27 quarters
|
|
2462
Pacific Biosciences
PACB
$892M
| $3.33M | ﹤0.01% |
1,088,146
+786,673
| +261% | +$3.22M |
2017 Q4
9 quarters
|
|
2463
CALL
MetLife
MET
$61.6B
| $3.33M | ﹤0.01% |
108,900
-422,900
| -80% | -$18.8M |
2016 Q3
14 quarters
|
|
2464
First Trust NYSE Arca Biotechnology Index Fund
FBT
$2.95B
| $3.33M | ﹤0.01% |
25,367
+7,350
| +41% | +$1.05M |
2013 Q2
27 quarters
|
|
2465
Ecopetrol
EC
$35.5B
| $3.33M | ﹤0.01% |
349,711
+39,467
| +13% | +$653K |
2014 Q1
24 quarters
|
|
|
NUAN
2466
DELISTED
Nuance Communications, Inc.
NUAN
| $3.33M | ﹤0.01% |
198,133
+40,824
| +26% | +$798K |
2013 Q2
27 quarters
|
|
2467
Amplify Online Retail ETF
IBUY
$120M
| $3.32M | ﹤0.01% |
80,087
-3,219
| -4% | -$158K |
2018 Q4
5 quarters
|
|
2468
iShares MSCI Intl Momentum Factor ETF
IMTM
$4.32B
| $3.31M | ﹤0.01% |
125,295
-8,095
| -6% | -$242K |
2017 Q4
9 quarters
|
|
2469
Inovio Pharmaceuticals
INO
$119M
| $3.31M | ﹤0.01% |
37,092
+22,922
| +162% | +$1.41M |
2014 Q3
22 quarters
|
|
|
LGTY
2470
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
| $3.31M | ﹤0.01% |
232,859
+222,633
| +2,177% | +$3.29M |
2017 Q4
9 quarters
|
|
|
FL
2471
PUT
DELISTED
Foot Locker
FL
| $3.31M | ﹤0.01% |
150,000
-50,000
| -25% | -$1.7M |
2019 Q2
3 quarters
|
|
2472
Sabre
SABR
$779M
| $3.3M | ﹤0.01% |
556,340
-357,871
| -39% | -$5.99M |
2014 Q2
23 quarters
|
|
2473
LGI Homes
LGIH
$1.08B
| $3.29M | ﹤0.01% |
72,943
+42,200
| +137% | +$3.13M |
2015 Q3
18 quarters
|
|
2474
Nektar Therapeutics
NKTR
$1.44B
| $3.29M | ﹤0.01% |
12,285
-110,266
| -90% | -$34.1M |
2013 Q2
27 quarters
|
|
|
USCR
2475
DELISTED
U S Concrete, Inc.
USCR
| $3.29M | ﹤0.01% |
181,339
+158,885
| +708% | +$4.89M |
2015 Q4
17 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2020 Portfolio in Review
As of Q1 2020, JP Morgan Chase held 6,012 positions worth $426B, down 21% from $536B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase deployed $14B of net new capital in Q1 2020, opening 362 new positions and adding to 2,382 existing holdings. Its largest new stake was NextEra Energy, Inc. 5.279% Corporate Units: 1,245,017 shares worth $54.9M.
By sector, the portfolio is most concentrated in Miscellaneous at 28% of assets, down from 28% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was JPMorgan BetaBuilders Japan ETF, an estimated $1.24B trimmed.
- JP Morgan Chase's largest Q1 2020 buy was NextEra Energy, Inc. 5.279% Corporate Units: 1,245,017 shares worth $54.9M.
- JP Morgan Chase added most to iShares S&P 500 Value ETF in Q1 2020, an estimated $2.05B increase.
- JP Morgan Chase's biggest Q1 2020 reduction was JPMorgan BetaBuilders Japan ETF, cutting an estimated $1.24B.
- JP Morgan Chase fully exited Liberty Property Trust in Q1 2020, selling an estimated $264M.
- JP Morgan Chase's ten largest holdings make up 18% of its $426B portfolio in Q1 2020.
- JP Morgan Chase opened 362 new positions and closed 692 in Q1 2020.
- JP Morgan Chase's portfolio value fell 21% quarter-over-quarter to $426B.
Based on JP Morgan Chase's 13F filing for Q1 2020, filed 12 May 2020.